re: Ann: Update on Bunawan and Bahayan Permit... With the new relaxed laws it's perfect time to get the rubber stamp
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling